CLSA

Summary

In 1986 was created CLSA, which is appeared as Corporate Investor. The fund was located in Asia if to be more exact in Hong Kong. The leading representative office of defined Corporate Investor is situated in the Hong Kong.

The current fund was established by Gary Coull, Jim Walker. We also calculated 11 valuable employees in our database.

The standard case for the fund is to invest in rounds with 3-4 partakers. Despite the CLSA, startups are often financed by Wu Capital, M Ventures, Jazz Venture Partners. The meaningful sponsors for the fund in investment in the same round are Rothschild & Co., Groupe Siparex, Auriga Partners. In the next rounds fund is usually obtained by Scottish Equity Partners, Triathlon Medical Venture Partners, New Science Ventures.

The fund has specific favorite in a number of founders of portfolio startups. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. We can highlight the next thriving fund investment areas, such as Medical Device, Biotechnology. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular portfolio startups of the fund, we may highlight Symphony Communication Services Holdings, BioVex, Akili Interactive Labs.

The important activity for fund was in 2019. When the investment is from CLSA the average startup value is more than 1 billion dollars. The common things for fund are deals in the range of 50 - 100 millions dollars. The higher amount of exits for fund were in 2013. The real fund results show that this Corporate Investor is 13 percentage points more often commits exit comparing to other companies. The fund is generally included in less than 2 deals every year. This CLSA works on 15 percentage points more the average amount of lead investments comparing to the other organizations.